PHAR
Price:
$13.34
Market Cap:
$938.08M
Pharming Group N.V. is a biopharmaceutical company dedicated to the creation and commercialization of protein replacement therapies and precision medicines. The firm concentrates its efforts on addressing rare diseases and critical unmet medical needs across the United States, Europe, and other international markets. Its primary commercialized product is Ruconest, a recombinant human C1 esterase inhibitor utilized for the acute treatment of hereditary angioedema. Pharming's development pipeline also includes rhC1INH, which is being investigated for conditions such as pre-eclampsia, acute kidney injury, and COVID-19. Additionally, the company is developing leniolisib, a phosphoinositide 3-kin...[Read more]
Industry
Biotechnology
IPO Date
2020-12-23
Stock Exchange
NASDAQ
Ticker
PHAR
According to Pharming Group N.V.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.00B. This represents a change of 13.93% compared to the average of 878.74M of the last 4 quarters.
The mean historical Enterprise Value of Pharming Group N.V. over the last ten years is 803.70M. The current 1.00B Enterprise Value has changed 12.36% with respect to the historical average. Over the past ten years (40 quarters), PHAR's Enterprise Value was at its highest in in the December 2019 quarter at 1.25B. The Enterprise Value was at its lowest in in the June 2016 quarter at 95.43M.
Average
803.70M
Median
847.06M
Minimum
146.53M
Maximum
1.30B
Discovering the peaks and valleys of Pharming Group N.V. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 429.32%
Maximum Annual Enterprise Value = 1.30B
Minimum Annual Increase = -38.41%
Minimum Annual Enterprise Value = 146.53M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 1.00B | 44.18% |
| 2024 | 694.84M | -27.30% |
| 2023 | 955.72M | 4.05% |
| 2022 | 918.52M | 47.28% |
| 2021 | 623.64M | -38.41% |
| 2020 | 1.01B | -21.94% |
| 2019 | 1.30B | 112.54% |
| 2018 | 610.36M | -21.30% |
| 2017 | 775.60M | 429.32% |
| 2016 | 146.53M | 17.92% |
The current Enterprise Value of Pharming Group N.V. (PHAR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
884.13M
5-year avg
838.91M
10-year avg
803.70M
Pharming Group N.V.’s Enterprise Value is less than Tango Therapeutics, Inc. (3.79B), less than Septerna Inc (1.63B), greater than Arbutus Biopharma Corp (881.65M), less than Fortrea Holdings Inc. (2.64B), less than ProKidney Corp. (1.30B), less than Bicara Therapeutics Inc. Common Stock (1.15B), less than Palvella Therapeutics, Inc. (1.55B), less than Mind Medicine (MindMed) Inc. (4.64B), greater than Kura Oncology, Inc. (952.83M), less than EyePoint Pharmaceuticals, Inc. (1.09B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 3.79B | $3.92B | |
| 1.63B | $1.68B | |
| 881.65M | $904.72M | |
| 2.64B | $1.67B | |
| 1.30B | $615.34M | |
| 1.15B | $1.47B | |
| 1.55B | $1.75B | |
| 4.64B | $1.56B | |
| 952.83M | $967.64M | |
| 1.09B | $1.15B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharming Group N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pharming Group N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Pharming Group N.V.'s Enterprise Value?
What is the highest Enterprise Value for Pharming Group N.V. (PHAR)?
What is the 3-year average Enterprise Value for Pharming Group N.V. (PHAR)?
What is the 5-year average Enterprise Value for Pharming Group N.V. (PHAR)?
How does the current Enterprise Value for Pharming Group N.V. (PHAR) compare to its historical average?